video1.0<iframe src="https://www.loom.com/embed/790ed349c1b74382911cfc6aa52c42ba" frameborder="0" width="1920" height="1440" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>14401920Loomhttps://www.loom.com14401920https://cdn.loom.com/sessions/thumbnails/790ed349c1b74382911cfc6aa52c42ba-26bfef8a22a284c8.gif592.7493In this video, I discuss the new VitalTrace device, a continuous scalp lactate monitor that measures fetal lactate levels rather than oxygen levels. It's crucial to clarify that high lactate levels indicate fetal compensation in low oxygen situations, not necessarily distress or harm. While this device represents a groundbreaking approach, we currently lack clinical trial research to confirm its effectiveness in preventing brain injury or reducing cesarean section rates. I emphasize the need for thorough research before this technology is widely implemented, as rushing it into clinical practice could lead to repeating past mistakes with fetal monitoring. I encourage viewers to advocate for proper evaluation and research to ensure the safety and efficacy of this new device.